A preliminary analysis of non-small cell lung cancer biomarkers in serum

Biomedical and Environmental Sciences

Volumn 16, Issue 2, 2003, Pages 140-148

  Xiao, Xue Yuan ^a   Tang, Ying ^a   Wei, Xiu Ping ^b   He, Da Cheng ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Non small cell lung cancer; SELDI mass spectrometry

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MASS SPECTROMETRY; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 1542711625     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Tran, Y., Bogler, O., Gorse, K., Wieland, H., Green, M.R., and Newsham, I.F. (1999). A novel member of the NF2/ERM4.1 superfamily with growth suppressing properties in lung cancer. Cancer Research 59, 35-43.
2. Wu, W., Kemp, B.L., Proctor, M.L., Gazdar, A.F., Minna, J.D., Hong, W.K., and Mao, L. (1999). Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Research 59, 1846-1851.
3. Li, Peiwen (2001). Diagnosis and Treatment of Lung Cancer. Beijing: Traditional Chinese Medicine Press of China, Chapter 2.
4. He, D. and Xiao, X. (2002). SELDI protein chip technology and its applications in Proteomics. Modern Instruments 1, 1-4.
5. Paweleta, C.P., Trock, B., Pennanen, M., Tsangaris, T., Magnant, C., Liotta, L.A., and Petricoin, E.F. (2001). Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis. Marker 17(4), 301-307.
6. Vlahou, A., Schellhammer, P.F., Mendrinos, S., Patel, K., Kondylis, F.I., Gong, L., Nasim, S., and Wright, G.L. (2001). Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. American Journal of Pathology 158 (4), 1491-1502.
7. Petricoin, E.F., Ardekani, A.M., Hitt, B.A., Levine, P.J., Fusaro, V.A., Steinberg, S.M., Mills, G.B., Simone, C., Fishman, D.A., Kohn, E.C., and Liotta, L.A. (2002). Use of proteomic patterns in serum to identify ovarian cancer. The Lancet 359, 572-577.
8. Smith, R.A., Mettlin, C.S., Davis, K.J., and Eyre, H. (2000). American cancer society guidelines for the early detection of cancer. CA. Cancer J. Clin 50 (1), 34-49.
9. Eggeling, F.V., Gawriljuk, A., Fiedler, W., Ernst, G., C;aissem, U., Klose, J., and Romer, I. (2001). Fluorescent dual colour 2D-protein gel electrophoresis for rapid detection of differences in protein pattern with standard image analysis software. Int. J. Mo.l Med. 8 (4), 373-377.
10. Bichsel, V.E., Liotta, L.A., and Petricoin, E.F. (2001). Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer J. 7(1), 69-78.
11. Eggeling, F.V., Davies, H., Lomas, L., Fiedler, W., Junker, K., Claussen, U., and Ernst, G. (2000). Tissue-specific microdissection coupled with Protein Chip array technologies: applications in cancer research. Biotechniques 29(5), 1066-1070.